A case report of severe hypoaldosteronism following unilateral adrenalectomy for aldosteronoma
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
Primary aldosteronism is characterized by hypertension and accounts for about 10% of hypertensive patients. Hyperkalemia and renal disease post adrenalectomy has been described in the literature. We present а case of primary aldosteronism with long standing hypertension (more than 10 years) with severe hypokalemia (1.9 mmol/l). Post unilateral adrenalectomy he had reduction in the blood pressure and became eukalemic. However, after 8 weeks of adrenalectomy patient developed hyperkalemia and increased serum creatinine, which resolved with fludrocortisone and attempt to discontinue fludrocortisone resulted in hyperkalemia and rising creatinine.
Screening of developing post-operative hyperkalemia should be actively considered in high-risk patients: older age, longer duration of hypertension, higher levels of aldosterone and severe hypokalemia before surgery, impaired estimated glomerular filtration rate and long-term treatment with spironolactone.
About the Author
Lilit EgshatyanRussian Federation
MD, PhD
References
1. Krotkova I.F., Ebzeeva E.Yu. Simptomaticheskie arterial'nye gipertenzii // Spravochnik poliklinicheskogo vracha. - 2017. - №3. - C. 21-25. [Krotkova IF, Ebzeeva EYu. Symptomatic arterial hypertension. Handbook for Practitioners Doctors. 2017;(3):21-25. (In Russ.)]
2. Mel'nichenko G.A., Platonova N.M., Bel'tsevich D.G., i dr. Pervichnyi giperal'dosteronizm: diagnostika i lechenie. Novyi vzglyad na problemu. Po materialam Proekta klinicheskikh rekomendatsii Rossiiskoi assotsiatsii endokrinologov po diagnostike i lecheniyu pervichnogo giperal'dosteronizma // Consilium Medicum. - 2017. - T. 19. - №4. - C. 75-85. [Melnichenko GA, Platonova NM, Beltsevich DG, et al. Primary hyperaldosteronism: diagnosis and treatment. A new look at the problem. According to the materials of the Russian Association of Endocrinologists clinical guidelines for primary hyperaldosteronism diagnosis and treatment. Consilium Medicum. 2017;19(4):75-85. (In Russ.)]
3. Chikhladze N.M., Favorova O.O., Chazova I.E. Semeinaya forma giperal'dosteronizma I tipa: klinicheskoe nablyudenie i obzor literatury // Terapevticheskii arkhiv. - 2018. - T. 90. - №9. - C. 115-122. [Chikladze NM, Favorova OO, Chazova IE. Family hyperaldosteronism type I: a clinical case and review of literature. Ter Arkh. 2018;90(9):115-122. (In Russ.)] https://doi.org/https://doi.org/10.26442/terarkh2018909115-122.
4. Tahir A, McLaughlin K, Kline G. Severe hyperkalemia following adrenalectomy for aldosteronoma: prediction, pathogenesis and approach to clinical management - a case series. BMC Endocr Disord. 2016;16(1):43. https://doi.org/https://doi.org/10.1186/s12902-016-0121-y.
5. Park KS, Kim JH, Ku EJ, et al. Clinical risk factors of postoperative hyperkalemia after adrenalectomy in patients with aldosterone-producing adenoma. Eur J Endocrinol. 2015; 172(6):725-731. https://doi.org/https://doi.org/10.1530/EJE-15-0074.
6. Fischer E, Hanslik G, Pallauf A, et al. Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy. J Clin Endocrinol Metab. 2012;97(11):3965-3973. https://doi.org/https://doi.org/10.1210/jc.2012-2234.
7. Chiang WF, Cheng CJ, Wu ST, et al. Incidence and factors of post-adrenalectomy hyperkalemia in patients with aldosterone producing adenoma. Clin Chim Acta. 2013;424:114-118. https://doi.org/https://doi.org/10.1016/j.cca.2013.05.017.
8. Tanase-Nakao K, Naruse M, Nanba K, et al. Chronic kidney disease score for predicting postoperative masked renal insufficiency in patients with primary aldosteronism. Clin Endocrinol (Oxf). 2014;81(5):665-670. https://doi.org/https://doi.org/10.1111/cen.12497.
9. Iwakura Y, Morimoto R, Kudo M, et al. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases. J Clin Endocrinol Metab. 2014;99(5): 1593-1598. https://doi.org/https://doi.org/10.1210/jc.2013-2180.
10. Reincke M, Rump LC, Quinkler M, et al. Risk factors associated with a low glomerular filtration rate in primary aldosteronism. J Clin Endocrinol Metab. 2009;94(3):869-875. https://doi.org/https://doi.org/10.1210/jc.2008-1851.
11. Sechi LA, Novello M, Lapenna R, et al. Long-term renal outcomes in patients with primary aldosteronism. JAMA. 2006;295(22):2638-2645. https://doi.org/https://doi.org/10.1001/jama.295.22.2638.
12. Yoneda T, Demura M, Takata H, et al. Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy. J Clin Endocrinol Metab. 2012; 97(4):1109-1113. https://doi.org/https://doi.org/10.1210/jc.2011-2563.
13. Demura M, Wang F, Yoneda T, et al. Multiple noncoding exons 1 of nuclear receptors NR4A family (nerve growth factor-induced clone B, Nur-related factor 1 and neuron-derived orphan receptor 1) and NR5A1 (steroidogenic factor 1) in human cardiovascular and adrenal tissues. J Hypertens. 2011;29(6):1185-1195. https://doi.org/https://doi.org/10.1097/HJH.0b013e32834626bb.
14. Conn JW, Hinerman DL. Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: morphological and functional studies. Metabolism. 1977;26(12):1293-1307. https://doi.org/https://doi.org/10.1016/0026-0495(77)90026-9.
15. Rodan AR, Huang CL. Distal potassium handling based on flow modulation of maxi-K channel activity. Curr Opin Nephrol Hypertens. 2009;18(4):350-355. https://doi.org/https://doi.org/10.1097/MNH.0b013e32832c75d8.
16. Liu W, Xu S, Woda C, et al. Effect of flow and stretch on the [Ca2+]i response of principal and intercalated cells in cortical collecting duct. Am J Physiol Renal Physiol. 2003;285(5): F998-F1012. https://doi.org/https://doi.org/10.1152/ajprenal.00067.2003.
17. McGowan CE, Saha S, Chu G, et al. Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol. South Med J. 2009;102(5):493-497. https://doi.org/https://doi.org/10.1097/SMJ.0b013e31819e8978.
18. Watson M, Abbott KC, Yuan CM. Damned if you do, damned if you don’t: potassium binding resins in hyperkalemia. Clin J Am Soc Nephrol. 2010;5(10):1723-1726. https://doi.org/https://doi.org/10.2215/CJN.03700410.
Review
For citations:
Egshatyan L. A case report of severe hypoaldosteronism following unilateral adrenalectomy for aldosteronoma. Endocrine Surgery. 2019;13(4):192-199. (In Russ.)
ISSN 2310-3965 (Online)